Check patentability & draft patents in minutes with Patsnap Eureka AI!

Novel anti-tumor compound and preparation method and application thereof

A technology of compounds and tumor inhibitors, applied in the fields of brain tumor inhibitors, glioma inhibitors, and spinal cord tumor inhibitors, which can solve the problems of few compounds and no central nervous system tumor inhibitory activity

Active Publication Date: 2019-05-17
TIANJIN MEDICAL UNIV
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0010] There are few studies on the compound, especially the research on tumor activity, and there is no report that it has central nervous system tumor inhibitory activity

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel anti-tumor compound and preparation method and application thereof
  • Novel anti-tumor compound and preparation method and application thereof
  • Novel anti-tumor compound and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0028] The preparation of embodiment 1 compound I

[0029] A bell of medicinal materials is crushed, impregnated with 95% ethanol for 3 days each time, 5 times in total, the impregnated solutions are combined and then concentrated under reduced pressure to obtain the ethanol extract extract. The ethanol extract was sequentially extracted three times with petroleum ether, concentrated under reduced pressure, and finally obtained the petroleum ether layer extract.

[0030] The petroleum ether layer extract was taken and subjected to preliminary separation by silica gel column chromatography; then purified by semi-preparative HPLC to obtain compound I as a light yellow solid, m.p.208-209°C. ESI-MS m / z:[M+H] + 483. 1 H-NMR (pyridine-d 5 ,400MHz)δ H :2.15(1H,m,H-2a),2.45(1H,m,H-2b),1.35(1H,m,H-3a),1.96(1H,m,H-3b),4.30(1H,d ,J=12.0Hz,H-5),2.85(1H,dd,J=11.6Hz,2.7Hz,H-6),3.56(1H,br d,J=11.9Hz,H-7),2.00(1H ,m,H-8a),1.75(1H,m,H-8b),2.94(1H,m,9a),2.38(1H,br d,J=13.5,H-9b),4.83(1H,s...

Embodiment 2

[0032] Embodiment 2 pharmacological experiment method and preparation

[0033] (1) Cell lines: Human glioblastoma cell lines U87MG and LN229 were purchased from ATCC cell bank in the United States.

[0034] (2) Cell recovery:

[0035] 1) Take out the frozen cells from the liquid nitrogen tank, quickly put them into the preheated 37°C water bath and shake continuously, so that they can be evenly heated and melted within 1 min, and then quickly transfer the thawed frozen cells into the pre-prepared container Centrifuge at low speed for 5 minutes at room temperature (800r / min);

[0036] 2) After centrifugation, discard the upper cryopreservation solution, leaving only the bottom sediment, add a small amount of culture medium, pipette the cells to make them evenly disperse in the culture medium to form a cell suspension, transfer to a 25ml culture bottle and replenish the culture medium to 5ml ;

[0037] 3) Place at 37°C, 5% CO 2 Cultivate in the incubator for 24 hours, discar...

Embodiment 3

[0054] Example 3 In vitro anti-cancer cell proliferation experiment (MTS experiment)

[0055] 1) Cultivate U87MG and LN229 cells until the cells grow to the logarithmic phase under an inverted microscope, digest with trypsin and make a concentration of 1×10 5 cell / ml cell suspension.

[0056] 2) Gently mix the above two cell suspensions, add 100 μl per well into a 96-well plate with a multi-channel micropipette, and the number of cells in each well is 1×10 4 indivual. Each type of cells was seeded into three 96-well plates, and the wells without adding cells, culture medium and drugs were set up as the zero-adjustment group in the experiment. The 96-well plate was cultured overnight in a cell culture incubator until a monolayer of cells was formed covering the bottom of the well.

[0057] 3) In the morning of the next day, after the cell monolayer covered the bottom of the well, the cell culture medium, temozolomide (10nM), temozolomide (100nM), temozolomide (1μM), temozolo...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a compound I and novel application of pharmaceutically-available salt of the compound I in preparation of tumor suppression medicine. The compound I is shown in the description.

Description

technical field [0001] The invention discloses the use of a compound isolated from traditional Chinese medicine Yikouzhong and a pharmaceutically available salt thereof in the preparation of central nervous system tumor inhibitors, especially as brain tumor inhibitors, spinal cord tumor inhibitors, glioma The use of inhibitors. Background technique [0002] The following background introduction related to the present invention is used to help the understanding of the present invention, but should not be considered as the prior art of the present invention. All cited publications are incorporated by reference in full. [0003] Central nervous system tumor is a kind of disease with special clinical significance among nervous system diseases. It is the most common central nervous system disease except cerebrovascular disease and craniocerebral injury with high disability and fatality rate. According to domestic epidemiological statistics, the annual incidence of brain tumors ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/352A61P35/00A61P25/00A61P25/28
Inventor 唐生安华丹
Owner TIANJIN MEDICAL UNIV
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More